The Workplace-Based Hypertension Management Program
ConditionHypertension
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorGuangxi Medical University
About this trial
This study aims to evaluate the effectiveness of a workplace-based, multicomponent hypertension management program for newly diagnosed patients. Investigators will recruit 512 participants (256 pairs) from the Kailuan Study in Tangshan, China. Participants will be randomly assigned to receive a Workplace-based Multicomponent Hypertension Management Program or Standard Workplace Health Management. The primary objective is to assess improvements in blood pressure control and hypertension-related health behaviors.
Eligibility criteria
Qualifiers
Adults aged 18-60 years
Newly diagnosed hypertension (per 2024 Chinese hypertension guideline criteria)
Employed in Kailuan Group workplace settings
Able to provide informed consent
Disqualifiers
Severe cardiovascular or renal disease at baseline
Psychiatric disorders affecting compliance
Pregnant or lactating women
Participation in other intervention trials
Trial design
Treatments tested in this trial
- Workplace-based Multicomponent Hypertension Management Program
- Routine workplace health education and management according to current guidelines.
Treatment groups
512 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov